Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome

Protic, D., Breeze, E., Mendoza, G., Zafarullah, M., Abbeduto, L., Hagerman, R., Coffey, C., Cudkowicz, M., Durbin-Johnson, B., Ashwood, P., Berry-Kravis, E., Erickson, C. A., Filipink, R., Gropman, A., Lehwald, L., Maxwell-Horn, A., Morris, S., Bennett, A. P., Prock, L., … Tassone, F. (2024). Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome. SAGE Open Medicine, 12. https://doi.org/10.1177/20503121241282401
Authors:
Dragana Protic
Elizabeth Breeze
Guadalupe Mendoza
Marwa Zafarullah
Leonard Abbeduto
Randi Hagerman
Christopher Coffey
Merit Cudkowicz
Blythe Durbin-Johnson
Paul Ashwood
Elizabeth Berry-Kravis
Craig A Erickson
Robin Filipink
Andrea Gropman
Lenora Lehwald
Angela Maxwell-Horn
Stephanie Morris
Amanda Palladino Bennett
Lisa Prock
Amy Talboy
Nicole Tartaglia
Jeremy Veenstra-VanderWeele
Flora Tassone
Affiliated Authors:
Jeremy Veenstra-VanderWeele
Author Keywords:
afq056
biomarkers
fragile x syndrome
mmp-9
mtor pathway
Publication Type:
Article
Unique ID:
10.1177/20503121241282401
Publication Date:
Data Source:
Scopus

Record Created: